6月9日，Hims & Hers Health盘中上涨5.06%，报28.5927美元/股，成交额9821.47万美元。消息面上，公司于6月2日完成对澳大利亚远程医疗公司Eucalyptus的收购，业务版图拓展至澳大利亚、加拿大、德国等国际市场，巩固其全球最大消费者健康平台地位。此外，市场跟踪数据显示公司近四周中已有三周实现销售额同比正增长，业务基本面边际向好提振多头信心。叠加与诺和诺德的合作进展顺利、肽类产品即将推出等预期，股价延续反弹走势。
Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.